Over the past twenty years combination chemotherapy has continued to produce small survival gains for patients with SCLC. We enter the next century enthusiastic about the array of new chemotherapeutic agents to evaluate and fascinated by the biological agents with the hope of achieving dramatic improvements in survival for our patients with SCLC.
|Original language||English (US)|
|Number of pages||24|
|Journal||Cancer Treatment and Research|
|State||Published - 2001|